Agios and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Ivosidenib in Greater China Biotech Investing
ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections Pharmaceutical Investing
aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate Pharmaceutical Investing
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes Pharmaceutical Investing
European Commission Grants Marketing Authorization for Gilead’s Biktarvy for the Treatment of HIV-1 Infection Pharmaceutical Investing
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer Pharmaceutical Investing
FARXIGA in Combination with ONGLYZA Demonstrates Similar Glycemic Control with Additional Benefits Pharmaceutical Investing
